Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Avigan, Mark I.
94  Ergebnisse:
Personensuche X
?
1

Drug-Induced Liver Injury in the Elderly: Consensus Stateme..:

Cohen, Eric B. ; Patwardhan, Meenal ; Raheja, Ritu...
Drug Safety.  47 (2024)  4 - p. 301-319 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Correction to: Drug-Induced Liver Injury in the Elderly: Co..:

Cohen, Eric B. ; Patwardhan, Meenal ; Raheja, Ritu...
Drug Safety.  47 (2024)  5 - p. 513-513 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Liver biopsy for assessment of suspected drug‐induced liver..:

Palmer, Melissa ; Kleiner, David E. ; Goodman, Zachary...
Alimentary Pharmacology & Therapeutics.  59 (2023)  2 - p. 201-216 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Lipidomic profiling of the hepatic esterified fatty acid co..:

Nagumalli, Suresh K. ; Willett, Rose A. ; de Conti, Aline...
The Journal of Nutritional Biochemistry.  109 (2022)  - p. 109108 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Non-alcoholic fatty liver disease-associated DNA methylatio..:

Tryndyak, Volodymyr P. ; Willett, Rose A. ; Avigan, Mark I....
Epigenetics.  17 (2022)  11 - p. 1462-1476 , 2022
Link: https://doi.org/10.1080/..
 
?
6

Deciphering the Dynamic Complexities of the Liver Microenvi..:

Wang, Tao ; Yeh, Matthew M. ; Avigan, Mark I...
The AAPS Journal.  23 (2021)  5 - p. , 2021
Link: https://doi.org/10.1208/..
 
?
7

Best practices for detection, assessment and management of ..:

Regev, Arie ; Avigan, Mark I. ; Kiazand, Alexandre...
Journal of Autoimmunity.  114 (2020)  - p. 102514 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Characterization of the variability in the extent of nonalc..:

Conti, Aline ; Tryndyak, Volodymyr ; Willett, Rose A....
The FASEB Journal.  34 (2020)  6 - p. 7773-7785 , 2020
Link: https://doi.org/10.1096/..
 
?
9

Consensus Guidelines: Best Practices for Detection, Assessm..:

Treem, William R. ; Palmer, Melissa ; Lonjon-Domanec, Isabelle...
Drug Safety.  44 (2020)  2 - p. 133-165 , 2020
Link: https://doi.org/10.1007/..
 
?
10

An Evaluation of Postmarketing Reports of Serious Idiosyncr..:

Kang, Sarah ; Brinker, Allen ; Jones, S. Christopher..
Drug Safety.  43 (2020)  12 - p. 1267-1276 , 2020
Link: https://doi.org/10.1007/..
 
?
11

Next‐Generation DILI Biomarkers: Prioritization of Biomarke..:

Roth, Sharin E. ; Avigan, Mark I. ; Bourdet, David...
Clinical Pharmacology & Therapeutics.  107 (2019)  2 - p. 333-346 , 2019
Link: https://doi.org/10.1002/..
 
?
12

Consensus guidelines: best practices for detection, assessm..:

Palmer, Melissa ; Regev, Arie ; Lindor, Keith...
Alimentary Pharmacology & Therapeutics.  51 (2019)  1 - p. 90-109 , 2019
Link: https://doi.org/10.1111/..
 
?
13

Consensus: guidelines: best practices for detection, assess..:

Regev, Arie ; Palmer, Melissa ; Avigan, Mark I....
Alimentary Pharmacology & Therapeutics.  49 (2019)  6 - p. 702-713 , 2019
Link: https://doi.org/10.1111/..
 
?
14

Liver safety assessment in clinical trials of new agents fo..:

Fontana, Robert J. ; Avigan, Mark I. ; Janssen, Harry L. A....
Journal of Viral Hepatitis.  27 (2019)  2 - p. 96-109 , 2019
Link: https://doi.org/10.1111/..
 
?
15

Hepatotoxicity of immune checkpoint inhibitors: An evolving..:

Suzman, Daniel L. ; Pelosof, Lorraine ; Rosenberg, Amy.
Liver International.  38 (2018)  6 - p. 976-987 , 2018
Link: https://doi.org/10.1111/..
 
1-15